BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 12, 2025
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 5, 2001
View Archived Issues
Clash Over Stem Cell Research Delayed As Bush Mulls Options
Read More
UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS JAN. 1 - DEC. 31, 2000: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY GROSS PROCEEDS*
Read More
UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS JAN. 1 - DEC. 31, 2000: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY AFTER-MARKET PERFORMANCE* #
Read More
UNDERWRITERS' PERFORMANCE ON IPOS FROM JAN. 1, 2000, TO DEC. 31, 2000: FULL CREDIT TO LEAD UNDERWRITER, RANKED BY GROSS PROCEEDS*
Read More
UNDERWRITERS' PERFORMANCE ON IPOS FROM JAN. 1, 2000, TO DEC. 31, 2000: FULL CREDIT TO LEAD UNDERWRITER, RANKED BY AFTER-MARKET PERFORMANCE#
Read More
UNDERWRITERS' PERFORMANCE ON IPOS FROM JAN. 1, 2000, TO DEC. 31, 2000: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY GROSS PROCEEDS*
Read More
UNDERWRITERS' PERFORMANCE ON IPOS FROM JAN. 1, 2000, TO DEC. 31, 2000: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY AFTER-MARKET PERFORMANCE#
Read More
UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS FROM JAN. 1, 2000, TO DEC. 31, 2000: FULL CREDIT TO LEAD UNDERWRITER, RANKED BY GROSS PROCEEDS*
Read More
UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS FROM JAN. 1, 2000, TO DEC. 31, 2000: FULL CREDIT TO LEAD UNDERWRITER, RANKED BY AFTER-MARKET PERFORMANCE#
Read More
